URMD -- Huge market potential Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jim s. who wrote (206)	2/14/1998 2:18:00 PM
From: Ken M	of 369

NEEDHAM, Mass., Feb 11- UroMed Corp Wednesday said it will restructure operations in the first quarter of 1998 to focus more on hospital-based sales and cut costs that is expected to save $11 million annually. The company said it will cut 40 jobs and take a $1 million one-time charge in the first quarter. The company said it will reduce its investment in the consumer-oriented continence care business, which will better be approached through marketing partners. These cuts are designed to "create a business model with a significantly lower break-even level," a release said. UroMed develops healthcare products related to prostate cancer, urinary incontinence, and breast cancer.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next